Study identifies low-dose aspirin's mechanisms of action in reducing cancer mortality
Low-dose aspirin may lower the risk for cancer metastasis and mortality by inhibiting both COX-1 and COX-2 pathways, according to data presented at the 13th Annual AACR International Conference on Frontiers in Cancer Prevention ...
Sep 30, 2014